免疫基因多态性与血小板输血和重组因子VII的不良反应相关,在Glanzmann血栓塞的治疗中
Majid Naderi1,2, Ilia Mirzaei3,4, Omid Seidizadeh5
1Genetics of Non-communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
概括
细胞因子基因的遗传变异,特别是IL-10,与Glanzmann血栓形成障碍 (GT) 患者治疗反应不佳有关. 这些发现可能有助于预测GT的治疗耐药性.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 对血小板和复合因子VII的反应不佳是Glanzmann血栓静止症 (GT) 患者的一个重大挑战.
- 在GT中治疗耐药性的风险因素仍然在很大程度上是未知的.
- 细胞因子基因的遗传变异是治疗耐药性的潜在贡献者.
研究的目的:
- 为了研究细胞因子基因中的遗传多态性和Glanzmann血栓硬化症治疗反应不佳之间的关联.
- 确定基因标记物,可以预测GT的抗血小板和复合因子VII疗法的耐药性.
主要方法:
- 使用TaqMan实时PCR进行IL-10和TNF-α多态的基因组化.
- 通过RFLP对IL-1,IL-1R1和IL-1RN基因多态的分析.
- 在体分析预测识别的多态的功能影响.
- 将GT患者 (耐药和非耐药) 和健康对照组之间的遗传特征进行比较.
主要成果:
- 在耐治疗的GT患者中观察到显著更高的IL-10基因变异 (rs1800896,GG基因型) 频率.
- 在IL-10和TNF-α基因 (rs3783550,rs3783553,rs3917356,rs2234463) 中发现了GT和特定多态之间的潜在相关性.
- 在体内预测表明,TNF-α rs1800629和IL-10 rs1800896的多态性影响着等位体表达,可能导致治疗反应不佳.
结论:
- IL-10和IL-1受体对手基因中的多态性与Glanzmann血栓硬化症治疗反应不佳有关.
- 进一步的研究表明IL-1α,IL1-β,IL-1R1和IL-1受体对手多形态在GT病原和进展中的潜在作用.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
696
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
696
01:24Disorders of Hemostasis
904
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
904
02:45Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
01:11Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K